Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.161NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.75NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.411NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.217NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.17 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.527NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.500NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.147NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.487NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.121NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AA.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AS.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.5.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBMNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CL.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BS.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.7.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used